CXCR6 and metabolic dysfunction-associated steatohepatitis: In 2021, a detailed characterization of CD8+ T cells and the mechanisms by which they exacerbate MASH pathogenesis were proposed; CXCR6-expressing autoreactive CD8+ T cells were increased in both the mouse model of MASH (CDHFD).